lurbinectedin,pembrolizumab
jazz,pharmamar,merck
['sclc', 'luper']
 that s actually true, at least in the us. rx landscape has quickly evolved for ed-sclc in the last 5 years. when the luper trial was designed in 2017, we had no grade i level evidence of the role of io in sclc. designed ph3 trials considered io monotherapy enough and failed.
Medical Oncology ?? HGU Gregorio Marañón?@myESMO Faculty ?? Lung Cancer - Mesothelioma - Thymoma?Power to the patients #endlungcancer #lcsm